Interactive Financial Charts Not Available

India Glycols (INDIAGLYCO) | Financial Analysis & Statements

India Glycols Ltd. | Mid-cap | Basic Materials

₹1,818.50

4.47%

India Glycols vs Deepak Nitrite India Glycols vs Navin Fluorine India Glycols vs Deepak Fertilisers India Glycols vs Epigral India Glycols vs Archean Chemical India Glycols vs NIFTY 50 | Market

TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 8.6B

Gross Profit 3.3B 38.15%

Operating Income 1.1B 13.13%

Net Income 640.2M 7.42%

Balance Sheet Metrics

Total Assets 61.8B

Total Liabilities 39.2B

Shareholders Equity 22.6B

Debt to Equity 1.74

Cash Flow Metrics

Operating Cash Flow 1.0B

Free Cash Flow -426.9M

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

India Glycols Income Statement From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Revenue i	37.7B	32.7B	25.8B	28.1B	22.5B
Cost of Goods Sold i	24.1B	22.1B	16.3B	19.7B	15.4B
Gross Profit i	13.6B	10.6B	9.5B	8.5B	7.1B
Gross Margin % i	36.1%	32.3%	36.7%	30.0%	31.4%
Operating Expenses
Research & Development i	-	-	-	-	-
Selling, General & Administrative i	-	1.3B	1.1B	1.4B	1.1B
Other Operating Expenses i	7.3B	4.2B	4.8B	2.5B	2.8B
Total Operating Expenses i	7.3B	5.5B	5.9B	4.0B	3.9B
Operating Income i	4.0B	3.2B	2.3B	3.2B	2.1B
Operating Margin % i	10.5%	9.8%	9.1%	11.4%	9.2%
Non-Operating Items
Interest Income i	-	235.8M	247.2M	242.5M	92.9M
Interest Expense i	1.6B	1.1B	850.1M	579.9M	713.7M
Other Non-Operating Income	-	-	-	-	-
Pre-tax Income i	2.9B	2.2B	1.7B	3.7B	1.2B
Income Tax i	614.0M	503.2M	239.6M	394.3M	112.8M
Effective Tax Rate % i	21.0%	22.5%	14.5%	10.7%	9.4%
Net Income i	2.3B	1.7B	1.4B	3.4B	1.3B
Net Margin % i	6.1%	5.3%	5.5%	12.1%	5.9%
Key Metrics
EBITDA i	5.7B	4.3B	3.1B	4.2B	2.8B
EPS (Basic) i	-	₹55.87	₹45.55	₹109.77	₹42.51
EPS (Diluted) i	-	₹55.87	₹45.55	₹109.77	₹42.51
Basic Shares Outstanding i	-	30961500	30961500	30961500	30961500
Diluted Shares Outstanding i	-	30961500	30961500	30961500	30961500

Income Statement Trend

India Glycols Balance Sheet From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Assets
Current Assets
Cash & Equivalents i	68.4M	269.6M	19.7M	70.5M	33.9M
Short-term Investments i	1.2B	476.9M	457.0M	389.4M	1.7B
Accounts Receivable i	3.6B	3.8B	4.3B	4.0B	3.6B
Inventory i	11.7B	11.1B	7.5B	6.9B	6.1B
Other Current Assets	1.4B	1.8B	1.7B	2.0B	1.7B
Total Current Assets i	18.2B	19.4B	16.5B	16.1B	17.1B
Non-Current Assets
Property, Plant & Equipment i	38.3B	366.1M	213.3M	217.2M	229.9M
Goodwill i	13.7M	16.3M	19.0M	16.5M	18.7M
Intangible Assets i	13.7M	16.3M	19.0M	16.5M	18.7M
Long-term Investments	-	-	-	-	-
Other Non-Current Assets	63.8M	53.9M	80.4M	10.8M	166.3M
Total Non-Current Assets i	43.6B	36.7B	32.1B	30.2B	24.1B
Total Assets i	61.8B	56.2B	48.6B	46.3B	41.2B
Liabilities
Current Liabilities
Accounts Payable i	9.8B	11.7B	8.0B	6.8B	6.3B
Short-term Debt i	7.8B	6.0B	5.5B	5.1B	6.2B
Current Portion of Long-term Debt	-	-	-	-	-
Other Current Liabilities	1.8B	2.9B	2.4B	2.9B	2.6B
Total Current Liabilities i	23.2B	23.7B	18.6B	17.5B	17.7B
Non-Current Liabilities
Long-term Debt i	11.1B	7.5B	5.7B	5.4B	5.2B
Deferred Tax Liabilities i	4.4B	4.0B	3.6B	3.4B	3.6B
Other Non-Current Liabilities	28.4M	29.6M	1.2B	1.9B	2.6B
Total Non-Current Liabilities i	16.0B	11.9B	10.9B	11.1B	11.8B
Total Liabilities i	39.2B	35.7B	29.6B	28.6B	29.5B
Equity
Common Stock i	309.6M	309.6M	309.6M	309.6M	309.6M
Retained Earnings i	-	18.7B	17.2B	16.1B	9.8B
Treasury Stock i	-	-	-	-	-
Other Equity	-	-	-	-	-
Total Shareholders Equity i	22.6B	20.5B	19.0B	17.7B	11.7B
Key Metrics
Total Debt i	18.9B	13.5B	11.1B	10.4B	11.4B
Working Capital i	-5.0B	-4.3B	-2.2B	-1.4B	-575.0M

Balance Sheet Composition

India Glycols Cash Flow Statement From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Operating Activities
Net Income i	2.5B	2.1B	1.5B	3.5B	1.2B
Depreciation & Amortization i	-	-	-	-	-
Stock-Based Compensation i	-	-	-	-	-
Working Capital Changes i	1.1B	-2.9B	232.4M	-1.5B	624.2M
Operating Cash Flow i	5.0B	160.3M	2.6B	2.4B	2.5B
Investing Activities
Capital Expenditures i	-7.5B	-5.4B	-4.3B	-3.8B	-1.5B
Acquisitions i	-	-	0	4.6B	0
Investment Purchases i	-	-	-	-	0
Investment Sales i	0	1.8M	553.1M	1.5M	0
Investing Cash Flow i	-7.5B	-5.4B	-3.8B	622.5M	-1.7B
Financing Activities
Share Repurchases i	-	-	-	-	-
Dividends Paid i	-245.9M	-229.7M	-230.4M	-183.9M	-3.8M
Debt Issuance i	8.6B	4.6B	3.0B	3.2B	3.0B
Debt Repayment i	-3.8B	-2.4B	-1.7B	-4.1B	-1.6B
Financing Cash Flow i	4.6B	2.0B	1.1B	-1.1B	1.0B
Free Cash Flow i	-4.0B	-1.1B	-1.1B	-2.6B	-115.5M
Net Change in Cash i	2.1B	-3.2B	-159.3M	1.9B	1.9B

Cash Flow Trend

India Glycols Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 23.92

Price to Book 2.45

Price to Sales 1.44

Profitability Ratios

Profit Margin 6.35%

Operating Margin 11.07%

Return on Equity 10.24%

Return on Assets 3.74%

Financial Health

Current Ratio 0.78

Debt to Equity 83.85

Beta 0.26

Per Share Data

EPS (TTM) ₹74.50

Book Value per Share ₹728.70

Revenue per Share ₹1,240.27

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
indiaglyco	55.2B	23.92	2.45	10.24%	6.35%	83.85
Deepak Nitrite	247.1B	35.46	4.59	13.61%	8.42%	23.36
Navin Fluorine	245.8B	67.38	9.07	10.99%	13.90%	55.85
Deepak Fertilisers	185.6B	18.90	2.98	14.93%	9.21%	66.40
Epigral	79.2B	18.08	4.15	18.78%	17.26%	31.11
Archean Chemical	76.6B	48.78	4.11	8.70%	14.05%	12.58

Financial data is updated regularly. All figures are in the company's reporting currency.